Aris Global
ArisGlobal is a life sciences software company that provides cloud-based platforms for pharmacovigilance, regulatory affairs, clinical development, and medical affairs. It serves pharmaceutical, biotech, and contract research organizations by automating drug safety and regulatory workflows to support compliance and product lifecycle management. The company generates revenue through subscriptions and services for its SaaS products and related implementation and support.
- Industry-Specific ERP
- IT Consulting & Implementation
- Revenue
- $250.0M
- Employees
- 1,500
- Founded
- 1987
- Headquarters
- Chicago Loop, United States of America
What 44 Arbolus experts think of Aris Global
The NPS distribution skews positive with multiple promoters (NPS 9-10), a significant share of passives (NPS 7-8), and a minor but notable portion of detractors (NPS ≤6). Renewal intent is largely strong among high-spend, established pharma clients, while pilot or recent users and some influencers express uncertainty or negative intent. Stickiness appears robust for deployments over one year, especially in core R&D and quality and regulatory functions, suggesting entrenched workflows. Key expert themes include regulatory fit, strong ongoing support, and seamless integration, with weaknesses in onboarding complexity and cost for pilot customers.Overall Customer Sentiment: Positive
Who reviewed Aris Global
- C-Suite 62% (27)
- Director 31% (14)
- Manager 7% (3)
Employer names and spend open in the full report, along with the other 41 customers.
Everything 44 customers told us about Aris Global.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
27 Net Promoter Score, from 44 scored reviews- Promoters 18
- Passives 20
- Detractors 6
Cumulative NPS by month
+0 over 6 months- Feb 8
- May 8
- Jun 8
- Jul 8
- Sep 8
- Oct 8
Net Promoter Score across 7 reviews, accumulated up to each month. Category median 26 across 7 companies.
Praised
- Ease of Onboarding Enhancements
- Mid-Size Pharma Expansion
- Flexible Pricing Models
- Reliable Long-term Platform
Criticised
- Pricing Concerns for Smaller Clients
- Onboarding Complexity for Pilots
- Mixed Sentiment Among New Users
- New Entrants and Disruptors
What customers say
Renewal intent
Plan to renew 57%Plan to renew, by seniority
- 44% 18 answers
- 75% 8 answers
- 100% 1 answer
- 100% 1 answer
- 8.6/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
- 1/10 Average score from customers not renewing
Top alternatives
Most weighed by Aris Global customers
Report
More in Data & Analytics and ERP Software
Other companies in both categories with a customer report.
For people who use Aris Global
Do you use Aris Global at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 44 customers of Aris Global have already contributed
Takes a few minutes. Your identity stays anonymous.